Kristyn Esteves

ORCID: 0000-0001-6345-1149
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Pregnancy and preeclampsia studies
  • Maternal and fetal healthcare
  • Gestational Diabetes Research and Management
  • Preterm Birth and Chorioamnionitis
  • Prenatal Screening and Diagnostics
  • Pregnancy-related medical research
  • Neurological Complications and Syndromes
  • Reproductive System and Pregnancy
  • Fetal and Pediatric Neurological Disorders
  • Parvovirus B19 Infection Studies
  • Genomics and Rare Diseases
  • Blood disorders and treatments
  • Immunodeficiency and Autoimmune Disorders
  • Assisted Reproductive Technology and Twin Pregnancy
  • Bariatric Surgery and Outcomes

University of Maryland, Baltimore
2021-2024

University of Maryland Medical Center
2023

University of Connecticut
2019-2021

A 26-year-old gravida 5, para 1-0-3-1 woman was referred to our fetal center at 21 weeks and 1 day of gestation for a suspected cardiac defect. Fetal echocardiography revealed findings consistent with unbalanced ventricles (right larger than left), large atrioventricular septal defect, small aortic valve diameter, arch forward flow (Figs 1A–C, Video 1). In addition the complex ultrasonographic assessment growth restriction, increased nuchal fold, elevated umbilical artery Doppler indices....

10.1542/neo.25-6-e385 article EN NeoReviews 2024-06-01

Preterm premature rupture of membranes is associated with 30% all preterm births. The weakening amniotic an increase in matrix metallopeptidases (MMPs) along a decrease their inhibitors, tissue inhibitor (TIMPs). Additionally, granulocyte-macrophage colony-stimulating factor (GM-CSF) has been shown to weaken fetal in-vitro. We hypothesize pregnant mice treated GM-CSF lead increased MMPs:TIMPs resulting membrane and birth.Pregnant CD-1 on gestational day 17 received either intrauterine...

10.1111/aji.13424 article EN American Journal of Reproductive Immunology 2021-03-27

Objective The objective of our study was to investigate the effect impaired glucose metabolism (IGM) and ultrasound (US) findings consistent with hyperglycemia on maternal neonatal outcomes. Study Design This a retrospective case-control singleton, nonanomalous pregnancies an elevated 1-hour screening test (GST) completed after 23 weeks gestation. IGM defined as GST >130, but less than two abnormal values 3-hour tolerance (GTT). Gestational diabetes or more GTT. Ultrasound evidence...

10.1055/s-0042-1758486 article EN American Journal of Perinatology 2022-11-11
Coming Soon ...